Publication | Open Access
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
227
Citations
38
References
2013
Year
ClinicalTrials.gov NCT00703469.
| Year | Citations | |
|---|---|---|
Page 1
Page 1